Utah AI Refills with Organizational NPI Demand EHR Flags, Governance

• Utah’s Office of Artificial Intelligence Policy approved a yearlong regulatory-sandbox pilot letting Doctronic autonomously renew about 190 non-controlled chronic medications without real-time clinician sign-off.

• Expect admission and dispensing friction: EHRs may show an organizational prescriber (Doctronic’s group National Provider Identifier, NPI) with no AI rationale, and cross-state validity is unclear. That creates urgent needs for governance, audit trails, and visible order-source flags during verification.

• Structural and data provenance: AI renewals can appear in medication histories listing an organizational prescriber with no clinical rationale. EHR teams should add NPI-based flags and visible source attribution, but doing so requires vendor work, build time, and staff retraining.

• Operational safety net: Admission medication reconciliation loses a reachable prescriber and often lacks dose rationale, creating verification dead ends. Treat AI renewals as provisional inputs requiring attending review for discrepancies, but expect additional clicks and possible delays unless workflows and escalation paths are prebuilt.

• Governance and liability: Cross-state validity is unsettled when the prescriber of record is an organization rather than a licensed individual. Pharmacy leaders should update acceptable-prescription policies, route AI-originated renewals to Pharmacy and Therapeutics and legal review, and secure audit logs to reduce regulatory and claims risk.

Treat this as a near-term governance and operational risk: add EHR flags for AI refills, clarify prescriber rules, and assign an owner to track interstate acceptance.

• Ordering and data path: Renewals flow via Surescripts from Doctronic Physicians Group (organization National Provider Identifier, NPI 1790578466) and populate medication history—not inpatient orders. EHRs list an organization prescriber and NCPDP SCRIPT lacks an AI flag or documented rationale. Automated dispensing cabinets (ADCs) are unchanged until clinicians enter continuation orders.

• Signature and responsibility: Physicians review and sign the first 250 renewals per drug class before the AI gains autonomy. Afterwards the prescriber of record is Doctronic’s organizational National Provider Identifier (NPI) and malpractice coverage applies, with outpatient liability tied to that prescriber. Hospital clinicians sign continuation orders for inpatient care.

• Referral and exceptions: When the AI marks an application ineligible it issues a code for a free video visit with a licensed physician. That clinician can produce a conventional e-prescription that appears as a human-signed order in pharmacy systems. Denials and referrals are reported monthly.

• Reporting and auditability: Doctronic submits renewal counts, sampled cases, and safety, timeliness, and cost measures to the Office of Artificial Intelligence Policy. The state plans to publish aggregate findings. Prescription-level logs and the AI’s clinical rationale are not exposed to EHRs or Pharmacy and Therapeutics committees without patient consent.